199 related articles for article (PubMed ID: 30637473)
1. STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes.
Andersen MN; Etzerodt A; Graversen JH; Holthof LC; Moestrup SK; Hokland M; Møller HJ
Cancer Immunol Immunother; 2019 Mar; 68(3):489-502. PubMed ID: 30637473
[TBL] [Abstract][Full Text] [Related]
2. STAT3 is over-activated within CD163
Andersen MN; Andersen NF; Lauridsen KL; Etzerodt A; Sorensen BS; Abildgaard N; Plesner T; Hokland M; Møller HJ
Cancer Immunol Immunother; 2022 Jan; 71(1):177-187. PubMed ID: 34061243
[TBL] [Abstract][Full Text] [Related]
3. Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription-3 and nuclear factor-kappa B in tumor cells and tumor-associated macrophages.
Fujiwara Y; Komohara Y; Ikeda T; Takeya M
Cancer Sci; 2011 Jan; 102(1):206-11. PubMed ID: 21073634
[TBL] [Abstract][Full Text] [Related]
4. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
5. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.
Hasita H; Komohara Y; Okabe H; Masuda T; Ohnishi K; Lei XF; Beppu T; Baba H; Takeya M
Cancer Sci; 2010 Aug; 101(8):1913-9. PubMed ID: 20545696
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3.
Fujiwara Y; Komohara Y; Kudo R; Tsurushima K; Ohnishi K; Ikeda T; Takeya M
Oncol Rep; 2011 Dec; 26(6):1533-7. PubMed ID: 21922144
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-specific nanotechnology-driven CD163 overexpression in human macrophages results in an M2 phenotype under inflammatory conditions.
Alvarado-Vazquez PA; Bernal L; Paige CA; Grosick RL; Moracho Vilrriales C; Ferreira DW; Ulecia-Morón C; Romero-Sandoval EA
Immunobiology; 2017 Aug; 222(8-9):900-912. PubMed ID: 28545809
[TBL] [Abstract][Full Text] [Related]
8. Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163.
Etzerodt A; Maniecki MB; Graversen JH; Møller HJ; Torchilin VP; Moestrup SK
J Control Release; 2012 May; 160(1):72-80. PubMed ID: 22306335
[TBL] [Abstract][Full Text] [Related]
9. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
10. Specific targeting of CD163
Etzerodt A; Tsalkitzi K; Maniecki M; Damsky W; Delfini M; Baudoin E; Moulin M; Bosenberg M; Graversen JH; Auphan-Anezin N; Moestrup SK; Lawrence T
J Exp Med; 2019 Oct; 216(10):2394-2411. PubMed ID: 31375534
[TBL] [Abstract][Full Text] [Related]
11. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
12. Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
De Beule N; De Veirman K; Maes K; De Bruyne E; Menu E; Breckpot K; De Raeve H; Van Rampelbergh R; Van Ginderachter JA; Schots R; Van Valckenborgh E; Vanderkerken K
J Pathol; 2017 Mar; 241(4):534-546. PubMed ID: 27976373
[TBL] [Abstract][Full Text] [Related]
13. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti-inflammatory functions in macrophages through two distinct mechanisms.
Do T; Tan R; Bennett M; Medvedovic M; Grom AA; Shen N; Thornton S; Schulert GS
J Leukoc Biol; 2018 Jan; 103(1):71-85. PubMed ID: 29345059
[TBL] [Abstract][Full Text] [Related]
15. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli.
Buechler C; Ritter M; Orsó E; Langmann T; Klucken J; Schmitz G
J Leukoc Biol; 2000 Jan; 67(1):97-103. PubMed ID: 10648003
[TBL] [Abstract][Full Text] [Related]
16. A novel strategy for inducing the antitumor effects of triterpenoid compounds: blocking the protumoral functions of tumor-associated macrophages via STAT3 inhibition.
Fujiwara Y; Takeya M; Komohara Y
Biomed Res Int; 2014; 2014():348539. PubMed ID: 24738052
[TBL] [Abstract][Full Text] [Related]
17. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.
Mori K; Haraguchi S; Hiori M; Shimada J; Ohmori Y
BMC Cancer; 2015 Aug; 15():573. PubMed ID: 26242181
[TBL] [Abstract][Full Text] [Related]
19. Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release.
Sierra-Filardi E; Vega MA; Sánchez-Mateos P; Corbí AL; Puig-Kröger A
Immunobiology; 2010; 215(9-10):788-95. PubMed ID: 20580464
[TBL] [Abstract][Full Text] [Related]
20. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma.
Komohara Y; Hasita H; Ohnishi K; Fujiwara Y; Suzu S; Eto M; Takeya M
Cancer Sci; 2011 Jul; 102(7):1424-31. PubMed ID: 21453387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]